Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shinva Medical Instrument CoSHSE:600587 -1.84%59 Debt-to-Equity is 0.14 as of Jun. 2026, which is 52% below its 10-year median of 0.29. GuruFocus rates SHSE:600587 with a GF Score™ of 59/100 and a GF Value™ of ¥15.83 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 698 Medical Devices & Instruments companies, Shinva Medical Instrument Co ranks better than 63.32% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Shinva Medical Instrument Co's Debt-to-Equity or its related term are showing as below:
SHSE:600587'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.14 Med: 0.29 Max: 1.3
Current: 0.14
During the past 13 years, the highest Debt-to-Equity Ratio of Shinva Medical Instrument Co was 1.30. The lowest was 0.14. And the median was 0.29.
SHSE:600587's Debt-to-Equity is ranked better than 63.32% of 698
companies
in the Medical Devices & Instruments industry
Industry Median: 0.24
vs SHSE:600587: 0.14
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Shinva Medical Instrument Co Debt-to-Equity Related Terms
Shinva Medical Instrument Co Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600587 vs ABT, SYK, MDT: Debt-to-Equity Comparison
For the Medical Devices subindustry, Shinva Medical Instrument Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shinva Medical Instrument Co Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shinva Medical Instrument Co's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Shinva Medical Instrument Co's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shinva Medical Instrument Co (SHSE:600587) has a Debt-to-Equity of 0.14 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Shinva Medical Instrument Co and its competitors. This is 52% below median its historical median of 0.29. Over the past decade, Shinva Medical Instrument Co's Debt-to-Equity has ranged from 0.14 to 1.30. According to the industry distribution chart, Shinva Medical Instrument Co ranks #256 out of 698 companies in the Medical Devices & Instruments industry, placing it in the top 36.7%.
Is Shinva Medical Instrument Co's Debt-to-Equity too high?
Shinva Medical Instrument Co's current Debt-to-Equity of 0.14 is 52% below median its 10-year median of 0.29. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 1.30. The Medical Devices & Instruments industry median Debt-to-Equity is 0.24. Shinva Medical Instrument Co's value of 0.14 is 41.7% below this industry median. Based on the distribution chart, Shinva Medical Instrument Co ranks #256 out of 698 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shinva Medical Instrument Co has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shinva Medical Instrument Co's Debt-to-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shinva Medical Instrument Co ranks #256 out of 698 companies for Debt-to-Equity. This puts Shinva Medical Instrument Co in the upper half of its industry. The industry median Debt-to-Equity is 0.24. Shinva Medical Instrument Co's value of 0.14 is 41.7% below this benchmark. Historically, Shinva Medical Instrument Co's own Debt-to-Equity has ranged from 0.14 to 1.30 over the past decade. While the company's 10-year median is 0.29 vs. the industry median of 0.24, Shinva Medical Instrument Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.24, based on 698 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shinva Medical Instrument Co's current Debt-to-Equity of 0.14 is 41.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Shinva Medical Instrument Co and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shinva Medical Instrument Co's current Debt-to-Equity is 0.14, which is 52% below median its own 10-year median of 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shinva Medical Instrument Co stock overvalued right now?
Based on GuruFocus' analysis, Shinva Medical Instrument Co (SHSE:600587) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥15.83, compared to a current price of ¥12.25 — trading 22.6% below its estimated fair value. The current Debt-to-Equity is 0.14, which is 52% below median its 10-year median of 0.29 and 41.7% below the Medical Devices & Instruments industry median of 0.24. Shinva Medical Instrument Co's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Shinva Medical Instrument Co (SHSE:600587), the current Debt-to-Equity is 0.14 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shinva Medical Instrument Co (SHSE:600587) Overvalued in 2026?
Based on GuruFocus' analysis, Shinva Medical Instrument Co stock appears to be undervalued.
The current stock price of ¥12.25 is trading 22.6% below its estimated GF Value™ of ¥15.83.
GuruFocus considers Shinva Medical Instrument Co to be Modestly Undervalued.
Key valuation signals for SHSE:600587:
Debt-to-Equity: 0.14 (52% below median its 10-year median of 0.29)
GF Value™: ¥15.83 vs. price of ¥12.25 (22.6% below fair value)
Industry Position: 41.7% below the Medical Devices & Instruments median (#256 of 698)
No single metric tells the full story. See the SHSE:600587 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shinva Medical Instrument Co Ltd manufactures medical instruments in China. Its main products include sterilizers and testing products, radiotherapy and digital diagnosis equipment, surgical instruments and pharmaceutical machinery.
59GF Score
Get the complete analysis for SHSE:600587
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600587 has been successfully added to your 
